Insider Transactions in Q2 2024 at Resmed Inc (RSMDF)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2024
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.09%
|
$209,000
$209.81 P/Share
|
|
Jun 07
2024
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,683
-3.22%
|
$3,098,113
$211.66 P/Share
|
|
Jun 07
2024
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,683
+3.12%
|
$1,233,372
$84.98 P/Share
|
|
Jun 04
2024
|
Michael J Rider Global General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
267
-3.98%
|
$55,002
$206.33 P/Share
|
|
May 24
2024
|
Carol Burt Director |
SELL
Bona fide gift
|
Indirect |
47
-0.31%
|
-
|
|
May 15
2024
|
Jan De Witte Director |
SELL
Open market or private sale
|
Direct |
360
-4.57%
|
$78,480
$218.29 P/Share
|
|
May 15
2024
|
Peter C Farrell Director |
SELL
Bona fide gift
|
Direct |
68,200
-43.33%
|
-
|
|
May 08
2024
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,000
-12.37%
|
$2,743,000
$211.37 P/Share
|
|
May 08
2024
|
Brett Sandercock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+10.25%
|
$1,212,000
$101.64 P/Share
|
|
May 07
2024
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,683
-3.22%
|
$3,171,528
$216.5 P/Share
|
|
May 07
2024
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,683
+1.57%
|
$1,233,372
$84.98 P/Share
|
|
Apr 29
2024
|
Carol Burt Director |
SELL
Bona fide gift
|
Indirect |
234
-1.54%
|
-
|
|
Apr 29
2024
|
Karen Drexler Director |
SELL
Open market or private sale
|
Direct |
425
-4.79%
|
$90,950
$214.92 P/Share
|